Breath sniffing device may pick cancer patients who respond to immunotherapy
NCT ID NCT04146064
First seen May 10, 2026 · Last updated May 24, 2026 · Updated 2 times
Summary
This study tested a breath analysis device (eNose) to see if it can predict which cancer patients will benefit from immunotherapy. Researchers collected breath samples from 190 adults with lung, melanoma, bladder, kidney, or head and neck cancers before treatment. The goal was to see if unique breath patterns could identify responders, potentially offering a cheap, non-invasive way to guide treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9, Canada
Conditions
Explore the condition pages connected to this study.